Literature DB >> 15003900

Circulating levels and promoter polymorphisms of interleukins-6 and 8 in pediatric cancer patients with fever and neutropenia.

Thomas Lehrnbecher1, Gudrun Fleischhack, Mitra Hanisch, Frank Deinlein, Arne Simon, Toralf Bernig, Stephen J Chanock, Thomas Klingebiel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15003900

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  4 in total

Review 1.  Management of febrile neutropenia in the era of bacterial resistance.

Authors:  Sehnaz Alp; Murat Akova
Journal:  Ther Adv Infect Dis       Date:  2013-02

Review 2.  Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer.

Authors:  Robert S Phillips; Ros Wade; Thomas Lehrnbecher; Lesley A Stewart; Alex J Sutton
Journal:  BMC Med       Date:  2012-01-18       Impact factor: 8.775

3.  Biomarkers for Diagnosing Febrile Illness in Immunocompromised Children: A Systematic Review of the Literature.

Authors:  Fabian J S van der Velden; Andrew R Gennery; Marieke Emonts
Journal:  Front Pediatr       Date:  2022-03-10       Impact factor: 3.418

4.  Pro-inflammatory cytokine ratios determine the clinical course of febrile neutropenia in children receiving chemotherapy.

Authors:  Mira Siegmund; Julia Pagel; Tasja Scholz; Jan Rupp; Christoph Härtel; Melchior Lauten
Journal:  Mol Cell Pediatr       Date:  2020-06-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.